Journal of Medicinal Chemistry p. 1771 - 1781 (1990)
Update date:2022-08-04
Topics:
Brown, Frederick J.
Yee, Ying K.
Cronk, Laura A.
Hebbel, Kevin C.
Krell, Robert D.
Snyder, David W.
A perception of structural similarities between two independent series of leukotriene antagonists (one emanating from FPL 55712 and one based upon the leukotrienes themselves) led to the discovery of a novel class of indole and indazole derived antagonists of peptidoleukotrienes.A systematic exploration of C-6 substituted 4-(indol-1-ylmethyl)-3-methoxybenzoic acids identified cyclopentylacetamide and cyclopentylurethane as preferred substituents.The corresponding indazoles were equipotent.These compounds are selective leukotriene antagonists with pKB values of 7.5-7.8 vs LTE4 on guinea pig trachea.
View MoreJiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
Linyi Shengxin Pharmaceutical R&D Co., Ltd
Contact:+86-18653953873
Address:West First of Yufeng Road, Yishui County
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Tianjin Ingenochem Technology Co.,Ltd
Contact:+86-22-23677060
Address:Hitech Green Industry Park K2-9-602, Nankai district
Guangxi Shanyun Biochemical Science and Technology Co., Ltd
Contact:+86-0772--6828887
Address:#2 Industrial Park of Luzhai County, Liuzhou, Guangxi, China
Doi:10.1021/jm8003834
(2008)Doi:10.1021/jo8007034
(2008)Doi:10.1021/ja00284a052
(1986)Doi:10.1016/j.tetlet.2008.05.100
(2008)Doi:10.1002/anie.200800586
(2008)Doi:10.3998/ark.5550190.0015.403
(2014)